Green tea:: prevention and treatment of cancer by nutraceuticals

被引：35

作者：

Béliveau, R ^{[1
]}

Gingras, D ^{[1
]}

机构：

[1] Hop Ste Justine UQAM, Ctr Canc Charles Bruneau, Mol Med Lab, Montreal, PQ H3T 1C, Canada

来源：

LANCET | 2004年 / 364卷 / 9439期

关键词：

D O I：

10.1016/S0140-6736(04)17076-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1021 / 1022

页数：2

共 10 条

[1] Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors [J].

Bergers, G ;

Song, S ;

Meyer-Morse, N ;

Bergsland, E ;

Hanahan, D .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (09) :1287-1295

[2] Angiogenesis inhibited by drinking tea [J].

Cao, YH ;

Cao, RH .

NATURE, 1999, 398 (6726) :381-381

[3] Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy [J].

de Botton, S ;

Coiteux, V ;

Chevret, S ;

Rayon, C ;

Vilmer, E ;

Sanz, M ;

de La Serna, J ;

Philippe, N ;

Baruchel, A ;

Leverger, G ;

Robert, A ;

Miguel, JS ;

Conde, E ;

Sotto, JJ ;

Bordessoule, D ;

Fegueux, N ;

Fey, M ;

Parry, A ;

Chomienne, C ;

Degos, L ;

Fenaux, P .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) :1404-1412

[4]

Demeule Michel, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P441, DOI 10.2174/1568011023353930

[5] Fundamental concepts of the angiogenic process [J].

Folkman, J .

CURRENT MOLECULAR MEDICINE, 2003, 3 (07) :643-651

[6] REDUCED RISK OF ESOPHAGEAL CANCER-ASSOCIATED WITH GREEN TEA CONSUMPTION [J].

GAO, YT ;

MCLAUGHLIN, JK ;

BLOT, WJ ;

JI, BT ;

DAI, Q ;

FRAUMENI, JF .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (11) :855-858

[7] Cancer chemoprevention by dietary constituents: a tale of failure and promise [J].

Gescher, Andreas J. ;

Sharma, Ricky A. ;

Steward, William P. .

LANCET ONCOLOGY, 2001, 2 (06) :371-379

[8]

Lamy S, 2002, CANCER RES, V62, P381

[9] VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia [J].

Lee, YK ;

Bone, ND ;

Strege, AK ;

Shanafelt, TD ;

Jelinek, DF ;

Kay, NE .

BLOOD, 2004, 104 (03) :788-794

[10] Phase I trial of oral green tea extract in adult patients with solid tumors [J].

Pisters, KMW ;

Newman, RA ;

Coldman, B ;

Shin, DM ;

Khuri, FR ;

Hong, WK ;

Glisson, BS ;

Lee, JS .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) :1830-1838

← 1 →